GNH USA

Europe — EMA

Olmesartan Medoxomilo Mylan

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomilo Mylan, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to manage high blood pressure in adult patients.

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomilo Mylan, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to manage high blood pressure in adult patients. GNH USA supplies Olmesartan Medoxomilo Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Medoxomilo Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan medoxil is an angiotensin II receptor antagonist indicated for several cardiovascular conditions.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: used as part of combination therapy to improve symptoms and outcomes. - Diabetic nephropathy: helps protect kidney function by controlling blood pressure. - Post‑myocardial infarction: aids in long‑term blood pressure control after a heart attack. - Stroke prevention: contributes to secondary prevention of ischemic stroke in hypertensive patients.

What are the side effects of Olmesartan Medoxomil?

Olmesartan medoxil may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhea

Serious or Rare Side Effects: - Angioedema - Hyperkalemia - Acute kidney injury - Severe hypotension - Liver enzyme elevation - Allergic skin reactions

What precautions apply to Olmesartan Medoxomil?

When prescribing Olmesartan medoxil, clinicians should consider several safety aspects.

- Renal function monitoring: assess baseline creatinine and eGFR before initiation. - Electrolyte assessment: check serum potassium levels periodically. - Pregnancy contraindication: avoid use during pregnancy due to fetal toxicity. - Drug interactions: review concomitant medications that affect potassium or renal function. - Hypotension risk: monitor blood pressure after the first dose, especially in volume‑depleted patients. - Store at ambient temperature: keep the tablets in the original packaging  

Store  

What does Olmesartan Medoxomil interact with?

The safety profile of  OlOl    

Major  a  t 

t  t

Frequently asked questions

 +
 
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Olmesartan Medoxomil
Route
Oral Use
Manufacturer
Viatris Limited
Origin
EU

Related products